Brief: Amplia Therapeutics Signs Collaboration And Supply Agreement With Lilly
BRIEF-Amplia Therapeutics Signs Collaboration And Supply Agreement With Lilly Aug 4 (Reuters) - Amplia Therapeutics Ltd ATX.AX:
AMPLIA SIGNS COLLABORATION AND SUPPLY AGREEMENT WITH LILLY
AND LILLY TO EVALUATE NARMAFOTINIB AND OLOMORASIB COMBINATION
TO BEGIN STUDY IN LATE 2026 IN AUSTRALIA AND USA
SIGNS COLLABORATION AGREEMENT WITH LILLY FOR NSCLC STUDY
Further company coverage: ATX.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Amplia Therapeutics
See all newsBrief: Amplia Therapeutics Signs Collaboration And Supply Agreement With Lilly
Australia's Amplia rises to 4-month high on Eli Lilly cancer drug trial collaboration
Brief: Amplia Therapeutics Says Warwick Tong Will Retire As Board Chairman
Brief: Amplia Therapeutics Reports Four Additional Complete Responses And Improved Overall Survival Data In Accent Pancreatic Cancer Trial
Brief: Amplia Therapeutics Requests Trading Halt Pending Clinical Trial Results Announcement